Richter BioLogics is a world-class and expanding cGMP contract manufacturer (CDMO) of biopharmaceuticals, specialising in products derived from bacteria and yeast, based in Germany. We are recognised as a strong and experienced partner that offers one-stop solutions, including consultancy services.
Over the past 35+ years, Richter BioLogics has gained extensive experience in the development and manufacture of various product classes such as proteins, antibodies (VHH, Fab fragments, nanobodies), plasmid DNA (pDNA) using our proprietary pART process and vaccines. The company currently operates one development facility and three cGMP microbial production facilities. Richter BioLogics has now taken the next step in responding to the global demand for CDMO services by adding two more production lines of 300L and 1500L capacity to its Bovenau site. The development facility in Hamburg has also been expanded to provide capacity for new customer projects. Richter BioLogics is committed to meeting its customers' expectations and bringing their products to market in a timely manner.
With flexibility, commitment to good manufacturing practice and total transparency, our experienced and motivated teams provide highly specialised contract development and manufacturing services to support the global pharmaceutical and biotechnology industries with process development and supply of products for clinical trials and commercial material.
This is continually validated by the major regulatory authorities, including EMA, FDA, ANVISA, PMDA, Health Canada and MFDS, as well as numerous customer audits.
Company Details
- Employees
- 181
- Founded
- -
- Address
- Suhrenkamp 59, Hamburg,22335,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.richterbiologics.eu
- Keywords
- Microbial-derived biopharmaceuticals, Strain development, Establishment of cell banks, Process development, Development and validation of analytical methods, including biological assays, Supply of products for clinic phase I - III, Commercial GMP manufacturing, In-house QC testing and release, Stability studies according to ICH - guidelines, Process Validation, PPQ, VHH/Nanobody production, pDNA production, RHB-pART process, protein production.
- HQ
- Hamburg
Richter Biologics Questions
Richter Biologics's website is https://www.richterbiologics.eu
Richter Biologics's LinkedIn profile is https://de.linkedin.com/company/richterbiologics
Richter Biologics has
181 employees.
View email and phone details for 181
employees at Richter Biologics.
Richter Biologics's industry is
Biotechnology Research
Richter Biologics's top competitors are
Allergopharma Gmbh & Co. Kg,
Indivumed,
Accellerate,
Evotec,
Life Science Nord,
Medac Group,
Nordmark Pharma Gmbh,
Altona Diagnostics,
Vivatis Pharma Gmbh,
Desitin Arzneimittel Gmbh.
Richter Biologics's categories are Biotechnology Research
Richter Biologics's founding year is 1987
